In-Vivo Imaging System Wins Award

With this award, which is known as the "Oscar of Invention,” R&D Magazine has recognized the company's Maestro in-vivo fluorescence imaging system as "one of the most technologically significant new products of the year.”

"This recognition is continued testament to the innovation that the team at CRi is delivering to the biomedical research market,” said George Abe, president and CEO of CRi. "This is Cri's third R&D 100 Award, and I am very proud of our people and their dedication to developing molecular imaging systems that enable our customers to perform more effective studies in critical areas such as drug discovery and cancer research.”

Fluorescence imaging uses non-invasive light-based methods to identify structures and processes deep within small animals, rapidly, and cost-effectively. The Maestro system is an improvement over other fluorescence-based in-vivo imaging systems because it provides considerably enhanced sensitivity, a high level of multiplexing capabilities, and quantitative accuracy. Using patented CRi technology, the system effectively removes undesirable signals such as autofluorescence from images taken of small-animal models, thus allowing researchers to see fluorescent signals easier, faster, and more accurately. It allows the use of multiple fluorophores, detecting and separating even spectrally overlapping and hard-to-distinguish signals. These improvements over existing monochromatic in-vivo imaging systems were also recognized by the Academy of Molecular Imaging, which awarded its top basic science abstract award to CRi at its 2005 annual meeting.

"The Maestro system is revolutionizing small-animal fluorescence imaging, finally allowing researchers to realize the full potential of fluorescence-based methodologies,” said James Mansfield, product manager, CRi. CRi is a leading provider of liquid crystal based imaging technology.




Related Links:
CRi